Diagnosis and Management of Acute Exacerbations of COPD – Pharmacology CME

ebmedicine.net
diagnosis-and-management-of-acute-exacerbations-of-copd-pharmacology-cme

As more and more patients present to the ED with symptoms that suggest an acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD) –worsening dyspnea, cough and sputum production – emergency clinicians can improve patient comfort and possibly mitigate morbidity and mortality with the right testing and treatment interventions:

  • COPD is a clinical diagnosis, but some tests can exclude comorbid conditions
  • When to give antibiotics and when to culture
  • The SpO2 range to aim for
  • ECG findings typical of COPD
  • The role of ultrasound
  • Oxygen, bronchodilators, corticosteroids, and antibiotics: which ones, and how much?
  • Reviewing noninvasive ventilation and intubation options

More than 1.7 million patients per year present to the emergency department requiring treatment for chronic obstructive pulmonary disease (COPD), with about 20% requiring inpatient hospitalization. This costs the United States, directly and indirectly, between $35 and $50 billion each year. The GOLD guidelines, updated in 2016, contain a consensus definition for acute exacerbation of COPD, risk assessment, and evidence-based management strategies.

Read More